ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET ANALYSIS

Organ Transplant Immunosuppressant Drugs Market, By Drug Class (Calcineurin Inhibitors, Antiproliferative Agents, mTOR Inhibitor, Steroids, Antibodies), By Transplant Type (Kidney, Liver, Heart, Lung, Pancreas, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : Sep 2023
Code : CMI2495
Pages :176
Formats :
Excel and PDF
Industry : Pharmaceutical

Leading Companies

Global Organ Transplant Immunosuppressant Drugs Market - Key Players

The major players operating in the global organ transplant immunosuppressant drugs market include Astellas Pharma, Genzyme Corporation, Accord Healthcare Ltd., Watson Pharmaceuticals, Inc., Novartis AG, Mylan Laboratories, Inc., GlaxoSmithKline plc., Belcher Pharmaceuticals LLC, Leo Pharma As, Glenmark Pharmaceuticals Ltd., TFF Pharmaceuticals, Inc., TolerogenixX GmbH, Veloxis Pharmaceuticals Inc., Dr. Reddy’s Laboratories Ltd., Panacea Biotec Ltd., Strides Pharma Global Pte Ltd., and Hoffman La Roche.

ORGAN TRANSPLANT IMMUNOSUPPRESSANT DRUGS MARKET ANALYSIS

Leading Companies

Organ Transplant Immunosuppressant Drugs Market Report Snapshots

EXISTING CLIENTELE